Inpharma Weekly

, Volume 1333, Issue 1, pp 13–13 | Cite as

Irinotecan plus cisplatin is active in the treatment of gastric carcinoma

Clinical study
  • 4 Downloads

Keywords

Carcinoma Toxic Effect Neutropenia Median Survival Partial Response 

Copyright information

© Adis International Ltd 2002

Personalised recommendations